tetrahydropalmatine has been researched along with Leukemia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cao, J; Chen, D; Chen, L; Du, X; Fan, Z; Li, K; Li, S; Lin, L; Liu, X; Lu, Y; Ma, J; Pei, R; Sha, K; Shi, X; Tang, S; Wu, J; Ye, P; Zhang, B; Zhang, P; Zhuang, X | 1 |
1 other study(ies) available for tetrahydropalmatine and Leukemia
Article | Year |
---|---|
L-Tetrahydropalmatine Induces Apoptosis in EU-4 Leukemia Cells by Down-Regulating X-Linked Inhibitor of Apoptosis Protein and Increases the Sensitivity Towards Doxorubicin.
Topics: Apoptosis; Berberine Alkaloids; Cell Line, Tumor; Doxorubicin; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Humans; Leukemia; Proto-Oncogene Proteins c-mdm2; RNA, Small Interfering; Tumor Suppressor Protein p53; X-Linked Inhibitor of Apoptosis Protein | 2017 |